[{"Assets_0_Q2_USD":480159000.0,"CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q2_USD":-1.17,"EarningsPerShareBasic_2_Q2_USD":-1.16,"EarningsPerShareDiluted_1_Q2_USD":-1.17,"EarningsPerShareDiluted_2_Q2_USD":-1.16,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":20909000.0,"NetIncomeLossConverted_1_Q2_USD":-14106000.0,"NetIncomeLossConverted_2_Q2_USD":-14020000.0,"OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q2_USD":48625000.0,"RevenuesConverted_2_Q2_USD":103146000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q2_USD":191917000.0,"Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":12085000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":12045000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":12085000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":12045000.0,"filed":"20210806","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2021.0","name":"ANI PHARMACEUTICALS INC","period":"20210630","qtrs":"1","uom":"USD"}]